Advancing Personalized Cancer Medicine Through Research
- Upcoming Change to Our Fee Structure: We are pleased that we were able to extend our 2015 prices for an additional year. University policy requires us to adjust our service fees, effective Aug 1st, as we are required to operate under a nonprofit cost recovery system. Our goal is to provide the highest quality data in a timely manner while recouping our full operating costs. The new pricing will reflect recent increases in reagent and labor costs. We look forward to working with you on your upcoming research projects! (Posted 7/13/17)
- Newest CPCT faculty member, Shailja Pathania PhD, seeks new clues to hereditary breast cancer. (posted 3/30/17)
- Click here for past announcements.
The Center for Personalized Cancer Therapy (CPCT) Genomics Core enables UMass Boston investigators and academic and industry collaborators to carry out basic and translational genomics research, leveraging cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. The Genomics Core helps investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.